EU Adds 9 Startups to Contribute Data to Copernicus Mission
The European Union (EU) has added nine startups -- including Spain-based Satlantis, the parent company of UF startup Satlantis LLC -- to contribute data to the Copernicus project. Each startup will receive a 5 million euro contract to provide additional data to Copernicus.
Kate Therapeutics Debuts With $51 Million Series A To Develop Next-Generation Genetic Medicines To Treat Muscle and Heart Diseases
Kate Therapeutics Inc., a next-generation gene therapy company, has emerged from stealth mode after securing a $51 million Series A financing round. The funding was co-led by Westlake Village BioPartners and Versant Ventures, with participation from Osage University Partners and UF Innovate | Ventures. Additionally, the company has granted Astellas Pharma Inc. an exclusive worldwide license to develop, manufacture, and commercialize KT430 for the treatment of X-linked myotubular myopathy (XLMTM).
Aurigo Software Partners With University of Florida To Develop Cutting-Edge Solution for Underwater Projects
Aurigo Software, the leading provider of capital planning and construction management software for infrastructure and private owners, is partnering with the University of Florida’s Department of Mechanical and Aerospace Engineering to develop a revolutionary system for underwater surveying, mapping, and inspection, provisionally named Bathydrone.
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
CohBar, Inc. and Morphogenesis, Inc., a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies, have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
Entrinsic Bioscience Unveils Animal Study on Breakthrough Hydration Technology
A patented blend of amino acids will be part of the next generation of oral rehydration solutions, according to an animal study conducted by a team of researchers at Entrinsic Bioscience. The study demonstrated that the blend of amino acids was more efficient in transporting electrolytes and fluids than the glucose-based oral rehydration solution (ORS) recommended by the World Health Organization. The formula also decreased epithelial anion channel activity and improved intestinal barrier function at a greater level. The two formulas were tested in animals which had diarrhea induced through cholera toxin.
SATLANTIS Signs a Strategic Alliance With SuperSharp in the UK
SATLANTIS MICROSATS, S.A., the largest European provider of high-resolution optical payloads for small satellites, announced that it has entered into a strategic alliance with SuperSharp Space Systems Ltd., a University of Cambridge spin-off specialized in thermal infrared payloads for Earth Observation satellites, giving it a presence in Spain, the U.K., and the United States (with UF startup SATLANTIS LLC located in UF Innovate | Accelerate @ The Hub).
Entrinsic Bioscience Shares Breakthrough in Rehydration Technology
Groundbreaking research conducted by a team of leading researchers at Entrinsic Bioscience (EBS) and the University of Florida revealed significant findings that will change the way we understand amino acid combinations and represents the next generation of Oral Rehydration Solutions (ORS).
A UF Professor Emeritus of Medicine and an Engineering Alumna Elected for Florida Inventors Hall of Fame
A University of Florida ophthalmology professor emeritus who has led a decades-long effort to reverse genetic forms of vision loss and an engineering alumna who is a pioneer in the semiconductor polishing industry are among 10 new members of the Florida Inventors Hall of Fame announced today.
University of Florida Ranked Top 100 Worldwide Universities Granting U.S. Utility Patents in 2022
According to the National Academy of Inventors' annual list of Top 100 worldwide university utility patent holders, the University of Florida was ranked 16th overall in 2022.
ASGCT Honors UF Scientist with 2023 Outstanding New Investigator Award
The American Society of Gene & Cell Therapy (ASGCT) has awarded the Outstanding New Investigator Award for 2023 to Manuela Corti, PhD from the University of Florida, in recognition of her contributions to the field of gene and cell therapy. Recipients of this award come from academia, research foundations, government, or industry.
